Total Funding
3
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1647353
Alliquais a biomedical company that develops, manufactures, and markets its proprietary products by utilizing a technology portfolio.
David Stefansky: Member, Board of DirectorsPast Role: HepaLife Technologies Inc, Managing Members- Stephen A. Brigido, Chairman, SAB: Chairman, SABPast Role: American Orthopaedic Foot and Ankle Society, Director
About the Company
Alliqua is a biomedical company focused on the development, manufacturing, and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings such as SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing.
The company
intends to pursue projects in the fields of the active ingredient and transdermal drug delivery, as well as advanced wound care. Alliqua’s core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.
